| Literature DB >> 25481335 |
Antonin Lamaziere1, Doriane Richard2, Pedro Bausero2, Ullah Barbe2, Kaouthar Kefi2, Claude Wolf1, Francesco Visioli3.
Abstract
Long-chain n-3 (or omega 3) fatty acids, namely docosahexaenoic acid (DHA, 22:6n-3) and eicosapentaenoic acid (EPA, 20:5n-3) have been attributed cardioprotective properties. In this study, we evaluated the incorporation of DHA into cardiomyocytes and the shift in the omega 3/omega 6 ratio after supplementation of primary cardiomyocyte culture. Results are compared with atrial tissue concentrations attained after prolonged feeding of rats. The major difference between in vitro vs. in vivo supplementation is the paradoxical accumulation of arachidonic acid in cultured cardiomyocyte. However, this increase does not give rise to a higher PGE2 production after cellular stimulation, as compared with controls, possibly because of the associated inhibition of sPLA2 by DHA. Notably, in vitro supplementations with DHA 10 to 25μM approximate in vivo pharmacological treatments.Entities:
Keywords: Arachidonic acid; Cardiomyocytes; Cardiovascular disease; Docosahexaenoic acid; Mass spectrometry; Phospholipids
Mesh:
Substances:
Year: 2014 PMID: 25481335 DOI: 10.1016/j.plefa.2014.11.004
Source DB: PubMed Journal: Prostaglandins Leukot Essent Fatty Acids ISSN: 0952-3278 Impact factor: 4.006